NEW YORK (GenomeWeb) – A pair of studies appearing in Nature Neuroscience yesterday uncovered epigenetic changes associated with the development of Alzheimer's disease.

For the studies, the two research teams conducted epigenome-wide association studies to search for DNA regions that were differentially methylated in people who had Alzheimer's disease as compared to those without the disease. While the researchers uncovered nearly a dozen differentially methylated regions, both groups homed in on a hypermethylated region at the ANK1 gene.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.